1. Kim,
H.,
Arnoletti,
P.J.,
Christein,
J.,
Heslin,
M.J.,
Posey,
A.J.,
Pednekar,
A.,
et al.
Pancreatic adenocarcinoma: a pilot study of quantitative perfusion and diffusion-weighted breath-hold magnetic resonance imaging. Abdom Imaging.
2014; 39(5): 1143.
2. Belousova,
E.,
Karmazanovsky,
G.,
Kriger,
A.,
Kalinin,
D.,
Mannelli,
D.,
Glotov,
A.,
et al.
Contrast-enhanced MDCT in patients with pancreatic neuroendocrine tumours: correlation with histological findings and diagnostic performance in differentiation between tumour grades. Clin Radiol.
2017; 72(2):150–158.
3. Tang,
M.Y.,
Zhang,
X.M.,
Chen,
T.W.,
Huang,
X.H.
Various diffusion magnetic resonance imaging techniques for pancreatic cancer. World Journal of Radiology.
2015; 7(12):424-437.
4. Luna,
A.,
Pahwa,
S.,
Bonini,
C.,
Alcalá-Mata,
L.,
Wright,
K.L.,
Gulani,
V.
Multiparametric MR Imaging in Abdominal Malignancies. Magnetic resonance imaging clinics of North America.
2016; 24(1):157-186.
5. Ma,
W.,
Li,
N.,
Zhao,
W.,
Ren,
J.,
Wei,
M.,
Yang,
Y.,
et.
al.
Apparent Diffusion Coefficient and Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Pancreatic Cancer: Characteristics and Correlation With Histopathologic Parameters. J Comput Assist Tomogr. 2016; 40(5): 709–716.
6. Kim,
H.,
Arnoletti,
P.J.,
Christein,
J.,
Heslin,
M.J.,
Posey,
A.J.,
Pednekar,
A.,
et al.
Pancreatic adenocarcinoma: a pilot study of quantitative perfusion and diffusion-weighted breath-hold magnetic resonance imaging. Abdom Imaging.
2014; 39(5): 1143.
7. Zhao,
M.,
Fu,
K.,
Zhang,
L.,
Guo,
W.,
Wu,
Q.,
Bai,
X.,
et al.
Intravoxel incoherent motion magnetic resonance imaging for breast cancer: A comparison with benign lesions and evaluation of heterogeneity in different tumor regions with prognostic factors and molecular classification.
Oncology Letters 16.4.
2018; 5100-5112.